U.S. International Trade Commission Reviews Violation Decision on Imported Urine Splash Guards


Estimated reading time: 4–5 minutes

Investigation Background

The investigation, numbered 337-TA-1430, began on January 13, 2025. It was based on a complaint from Kids By Parents, Inc. of Potomac, Maryland. The complaint said certain companies were importing and selling urine splash guards and components that violated section 337 of the Tariff Act of 1930. The alleged violation involves infringement of claims 1 and 2 of U.S. Patent No. 7,870,619 and claims 1-3 of U.S. Patent No. 11,812,901.

List of Respondents

The investigation named companies from China as respondents. There are two groups:

Defaulting Respondents (Did not respond to the complaint):

  • Maomaohouse (Shenzhen)
  • Le Sengyu (Guangzhou)
  • HealthSTEC (Hefei City)
  • Edermurs (Shenzhen)
  • Lishian (Shenzhen)

Settling Respondents (Resolved with settlement):

  • Tigaman (Shenzhen)
  • Junyxin (Xiamen City)
  • Eurbus (Shenzhen)
  • Sunyoka123 (Shenzhen)
  • SeLucky (Shenzhen)

The Office of Unfair Import Investigations also participated.

Key Decisions and Orders

Previously, the Settling Respondents were removed from the investigation due to settlements. The Defaulting Respondents were found in default after failing to reply to official notices and orders.

On June 30, 2025, Kids By Parents, Inc. filed a motion for summary determination of a violation of section 337 against the Defaulting Respondents. The motion requested:

  • A general exclusion order (GEO)
  • Cease and desist orders (CDOs)
  • A bond of 100% of the import value of infringing products during the period of Presidential review

The Office of Unfair Import Investigations supported this motion.

On September 17, 2025, the Administrative Law Judge (ALJ) issued an initial decision (ID):

  • The motion was granted for claims 1 and 2 of the ‘619 patent and claims 1 and 2 of the ‘901 patent.
  • The motion was not granted for claim 3 of the ‘901 patent.
  • Recommended a GEO and CDOs for Maomaohouse, Le Sengyu, HealthSTEC, and Lishian (not Edermurs).
  • Recommended a 100% bond on infringing articles during Presidential review.

Kids By Parents, Inc. filed to end the investigation concerning claim 3 of the ‘901 patent. The ALJ agreed, and the investigation was partially terminated for that claim.

Commission Review and Request for Comments

The ITC decided to review the initial decision regarding the domestic industry requirement. Other findings will not be reviewed.

The ITC may issue:

  • Exclusion orders, which could block the product from entering the U.S.
  • Cease and desist orders, which would require companies to stop further violations.

The Commission is asking for written comments on:

  • What kind of remedy should be ordered
  • Effects of any remedy on public health, competitive conditions, U.S. production, and consumers
  • Bond amount if a remedy is ordered

Deadlines for submitting comments are:

  • December 19, 2025 (initial submissions)
  • January 5, 2026 (reply submissions)

Written submissions must follow all Commission rules. Submissions may be public or confidential, but confidential documents must be labeled and handled according to the rules.

Next Steps

The President or U.S. Trade Representative has 60 days to take action on the ITC’s remedy, once ordered. During this time, products may still enter the U.S. if the required bond is posted.

Further information can be found on the ITC’s website. The official vote on this decision was held on December 3, 2025.

Contact for More Information

  • Houda Morad, Esq., Office of the General Counsel, U.S. International Trade Commission, (202) 708-4716.
  • ITC Electronic Docket: https://edis.usitc.gov

Issued December 3, 2025, by Lisa Barton, Secretary to the Commission.


Legal Disclaimer

This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.